Effect of Gengnianchun Recipe on bone mineral density, bone biomechanical parameters and serum lipid level in ovariectomized rats

Chinese Journal of Integrative Medicine

Volumn 12, Issue 2, 2006, Pages 132-136

  Liu, Ke Ju ^a   Wang, Wen Jun ^a   Li, Da Jin ^a   Jin, Hui Fang ^a   Zhou, Wen Jiang ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Bone biomechanics; Bone mineral density; Gengnianchun Recipe; Low density lipoprotein cholesterol; Postmenopausal osteoporosis; Total cholesterol

Indexed keywords

CHINESE DRUG; GENGNIANCHUN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HORMONE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NILESTRIOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCHEMICAL COMPOSITION; BONE DENSITY; CHINESE HERB; CHINESE MEDICINE; CHOLESTEROL BLOOD LEVEL; COLUMNAR EPITHELIUM; CONTROLLED STUDY; FEMALE; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; LUMBAR VERTEBRA; MITOSIS RATE; MORPHOLOGY; NONHUMAN; OSTEOPOROSIS; OVARIECTOMY; PRIORITY JOURNAL; RAT; STROMA CELL; TRIACYLGLYCEROL BLOOD LEVEL; UTERUS;

ANIMALS; BIOMECHANICS; BONE AND BONES; BONE DENSITY; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DRUGS, CHINESE HERBAL; ESTRIOL; FEMALE; LIPIDS; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; TRIGLYCERIDES; UTERUS;

EID: 33745814803     PISSN: 16720415     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02857360     Document Type: Article

References (15)

1. Cao LX, Mao QZ, Yu J. Clinical study of Gengnianchun on climacteric syndrome. Shanghai J Tradit Chin Med 1997; 31 (2): 33-35.
2. Wang WJ, Yu J, Wang J. The Prevention of "Gengnianchun" on experimental primary osteoporosis in rats. Shanghai J Tradit Chin Med 2001; 35(11): 47-49.
3. Wang WJ, Yu J, Wang J, et al. Effect of Gengnianchun on the pathomorphology of experimental primary osteoporosis. J Shanghai Med Univ 2000; 27(1): 54-56.
4. Seidlova-Wuttke D, Jarry H, Becher T, et al. Pharmacology of Cimicifuga racemosa extract BNO 1055 in rats: bone, fat and uterus. Maturitas 2003; 44 (Suppl 1): S39-S50.
5. Ceinos AM, Acosta EE, Martin PC, et al. Risk factors related to osteoporosis and age of onset of menopause in the general population. Aten Primaria 1999; 24 (3): 140-144.
6. Rosenberg L, Hennekens CH, Rosner B, et al. Early menopause and the risk of myocardial infarction. Am J Obstet Gynecol 1981; 139(1): 47-51.
7. Suda Y, Ohta H, Makita K, et al. Influence of bilateral oophorectomy upon lipid metabolism. Maturitas 1998; 29 (2): 147-154.
8. Genant HK, Baylink DJ, Gallagher JC. Estrogens in the prevention of osteoporosis in postmenopausal women. Am J Obstet Gynecol 1989; 161(6Pt2): 1842-1846.
9. Stampfer MJ, Colditz GA, Willett WC, et al. Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow up from the nurses' health study. N Engl J Med 1991;325(11): 756-762.
10. Henderson BE, Ross R, Pike MC. Hormonal chemoprevention of cancer in women. Science 1993;259(5095): 633-638.
11. Shiomi M, Ito T, Watanabe Y. Increase in hepatic low-density lipoprotein receptor activity during pregnancy in Watanabe heritable hyperlipidemia rabbits: an animal model for familial hypercholesterolemia. Biochem Biophys Acta 1987;917(1): 92-100.
12. Mabuchi H, Sakai Y, Watanabe A, et al. Normalization of low-density lipoprotein levels and disappearance of xanthomas during pregnancy in a woman with heterozygous familial hypercholesterolemia. Metabolism 1985;34(4): 309-315.
13. Honjo H, Tanaka K, Urabe M, et al. Menopause and hyperlipidemia: pravastain lowers lipid levels without decreasing endogenous estrogen. Clin Ther 1992; 14 (5): 699-707.
14. Abbey M, Owen A, Suzakawa M, et al. Effects of menopause and hormone replacement therapy on plasms lipids, lipoproteins and LDL-receptor activity. Maturitas 1999;33 (3): 259-269.
15. He Y, Lam TH, Li LS, et al. Triglyceride and coronary heart disease mortality in a 24-year follow-up study in Xi' an, China. Ann Epidemiol 2004; 14(1): 1-7.